The third transmembrane domains of the human B1 and B2 bradykinin receptor subtypes are involved in discriminating between subtype-selective ligands

被引：0
|
作者：
Fathy, DB [1 ]
Mathis, SA [1 ]
Leeb, T [1 ]
Leeb-Lundberg, LMF [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2751
引用
收藏
页码：A1328 / A1328
页数：1
相关论文
共 50 条
  • [31] Bradykinin B1, but not B2 receptor gene deletion reduces cardiac inflammation in experimental diabetic cardiomyopathy
    Westermann, D.
    Rutschow, S. R.
    Schultheiss, H. P. S.
    Pauschinger, M. P.
    Tschope, C. T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 787 - 787
  • [32] Nonpeptide bradykinin B2 receptor antagonists:: Conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists
    Dziadulewicz, EK
    Ritchie, TJ
    Hallett, A
    Snell, CR
    Davies, JW
    Wrigglesworth, R
    Dunstan, AR
    Bloomfield, GC
    Drake, GS
    McIntyre, P
    Brown, MC
    Burgess, GM
    Lee, W
    Davis, C
    Yaqoob, M
    Phagoo, SB
    Phillips, E
    Perkins, MN
    Campbell, EA
    Davis, AJ
    Rang, HP
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (11) : 2160 - 2172
  • [33] Constitutive activation of the human bradykinin B2 receptor induced by mutations in transmembrane helices III and VI
    Marie, J
    Koch, C
    Pruneau, D
    Paquet, JL
    Groblewski, T
    Larguier, R
    Lombard, C
    Deslauriers, B
    Maigret, B
    Bonnafous, JC
    MOLECULAR PHARMACOLOGY, 1999, 55 (01) : 92 - 101
  • [34] Kinin B1 but not B2 receptor agonists induce human neutrophil chemotaxis
    Ehrenfeld, P
    Millan, C
    Figueroa, J
    Nualart, F
    Figueroa, CD
    JOURNAL OF LEUKOCYTE BIOLOGY, 2004, : 33 - 34
  • [35] Negative and positive regulatory epitopes in the C-terminal domains of the human B1 and B2 bradykinin receptor subtypes determine receptor coupling efficacy to G9/11-mediated phospholipase Cβ activity
    Kang, DS
    Leeb-Lundberg, LMF
    MOLECULAR PHARMACOLOGY, 2002, 62 (02) : 281 - 288
  • [36] Molecular features characterizing non-peptide selectivity to the human B1 and B2 bradykinin receptors
    Rasaeifar, B.
    Lupala, C. S.
    Gomez-Gutierrez, P.
    Perez, Juan J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (01) : 11 - 14
  • [37] LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor
    Pruneau, D
    Luccarini, JM
    Fouchet, C
    Defrêne, E
    Franck, RM
    Loillier, B
    Duclos, H
    Robert, C
    Cremers, B
    Bélichard, P
    Paquet, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (02) : 365 - 372
  • [38] A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor
    Marceau, F
    Fortin, JP
    Morissette, G
    Dziadulewicz, EK
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (10-11) : 1529 - 1536
  • [39] Differential bradykinin B1 and B2 receptor regulation in cell death induced by hepatic ischaemia/reperfusion injury
    Paio, Mayra A.
    Kouyoumdjian, Maria
    Borges, Durval R.
    Nagaoka, Marcia R.
    CLINICAL SCIENCE, 2014, 127 (5-6) : 405 - 413
  • [40] Bradykinin B1 and B2 receptor gene expression in the brain of spontaneously hypertensive rats:: Relation to development of hypertension?
    Qadri, F
    Häuser, W
    Jöhren, O
    Dominiak, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R78 - R78
12345